Daily Edition · Page 1

THE DAILY INDEX

Technology, AI, software, security, crypto and business

Across today’s newsletters

Today’s Index

SPACEX ANNOUNCES FIRST HUMAN MISSION TO EVER FLY OVER THE PLANET'S POLES

SpaceX plans to perform the first-ever human space flight over the Earth's poles before the end of this year. The Fram2 mission crew will comprise a Chinese-born cryptocurrency entrepreneur, a polar explorer, a roboticist, and a filmmaker. They will fly aboard Crew Dragon Endurance, which will be fitted with a cupola for both photography and filming. This will be SpaceX's third free-flying mission aboard Crew Dragon.

DON'T GET CAUGHT BY SURPRISE: UNDERSTANDING THE READ AFTER WRITE PROBLEM

The "Read After Write" problem arises when a service attempts to read data immediately after writing it, but the changes may not be reflected in all nodes of the database yet. This is a common problem in distributed systems. This article goes over different database replication strategies, in terms of latency and data consistency. It suggests potential solutions, such as retrying reads, reading from the primary node, and accepting occasional inconsistencies depending on the application's requirements.

SCIENTISTS SAY THEY'VE FIGURED OUT HOW TO REGENERATE KNEE CARTILAGE

Scientists at Northwestern University have invented a goo that could open the door to regenerating human knee cartilage. The goo mimics the chemical structure of cartilage. Animal subjects who had their joints treated with the biomaterial grew new cartilage within six months. If the goo works in humans, it could benefit people who need knee replacement surgeries, athletes who experience ACL tears, and people who suffer from degenerative diseases like arthritis.

IT TOOK MY SAVINGS AND 14 YEARS — BUT I'M ABOUT TO BEAT ARTHRITIS

Simon Westbrook started a biotech company with his wife Dominique after they were made redundant by Pfizer in 2011. Their mission was to develop a game-changing drug to treat osteoarthritis. 14 years after starting their mission, the effectiveness of their company's treatment has exceeded all expectations. The treatment, which restores protective processes to diseased joints and enables the regeneration of affected tissues, can be delivered via a once-a-month injection. This article tells the story of how the drug was developed.

TLDR IndexPage 1